Michael Gelband’s Cognizant CTSH Stock Holding History

Michael Gelband’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-162,500	Closed	-$10.1M	–	1166
2019 Q4	$10.1M	Buy	162,500 +112,500	+225%	+$6.95M	0.19%	88
2019 Q3	$3.01M	Hold	50,000	–	–	0.11%	169
2019 Q2	$3.17M	Buy	+50,000	New	+$3.28M	0.13%	110

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Michael Gelband's CTSH Position: Q2 2026 in Review

Michael Gelband sold out of Cognizant (CTSH) in Q2 2026, closing a stake of 329,713 shares — an estimated $20.2M sold.

Michael Gelband first reported a position in CTSH in Q3 2019 and held it in 20 quarters. The position peaked at $20.2M in Q1 2026. 910 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

Michael Gelband reported no remaining Cognizant position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 329,713 Cognizant shares in Q2 2026, an estimated $20.2M.
Michael Gelband first reported a position in Cognizant in Q3 2019 and held it in 20 quarters.
Michael Gelband's Cognizant position peaked at $20.2M in Q1 2026.
910 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.